REDWOOD SHORES, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer. Mr. Waters brings approximately 20 years of finance and medical ...

Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, ...

Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The equities ...

In other recent news, Procept BioRobotics Corp reported its fourth-quarter 2024 earnings, revealing a revenue of $68.24 million, surpassing the forecast of $66.83 million. Despite this revenue beat, ...

Surgical robotics are on the rise, with a global market that’s expected to grow from $56 million in 2017 to $98 million by 2024, nearly doubling in that time. As such, there are a bunch of up and ...

On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...

Procept BioRobotics is also focusing on international expansion, with strong momentum noted in the UK and Japan markets. The company expects to maintain a gross margin of 64.5% in 2025, reflecting ...

In the latest quarter, 6 analysts provided ratings for PROCEPT BioRobotics (NASDAQ:PRCT), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

Fintel reports that on September 2, 2025, Oppenheimer upgraded their outlook for PROCEPT BioRobotics (NasdaqGM:PRCT) from Perform to Outperform. Analyst Price Forecast Suggests 73.03% Upside As of ...

"We began 2025 with strong performance, delivering total revenue growth of 55% in the first quarter. Procedural momentum remained robust heading into the second quarter, reinforcing our confidence ...